36 results for browsing: Unknown
Colin Begg, PhD
Colin Begg, PhD, is the incumbent of the Eugene W. Kettering Chair at Memorial Sloan-Kettering Cancer Center in New York, where he also serves as Chair of the Department of Epidemiology & Biostatistics and Associate Director for Population Sciences. Over his career, Dr. Begg has been involved in many areas of cancer research including clinical trials, diagnostic medicine, epidemiologic investigations, and health services research. His special focus has been the development of new statistical methods in these disciplines.
Hiltrud Brauch, PhD, Professor
Hiltrud Brauch completed her PhD at the University of Heidelberg, Germany, and postdoctoral studies as a Fogarty International Visiting Fellow at the National Institutes of Health (NIH), National Cancer Institute (NCI), Frederick, Maryland, USA. She works on the elucidation of breast cancer susceptibility genes with a strong focus on breast cancer pharmacogenomics and mechanistic approaches towards overcoming endocrine resistance. During her scientific career, she has held positions with increasing responsibilities currently being the deputy director of the Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology in Stuttgart, a non-profit ...
Katerina Gurova, MD, PhD
Dr. Katerina Gurova came to Roswell Park Comprehensive Cancer Center from Cleveland BioLabs, where she served as Director of Anti-Cancer Drug Discovery. Before joining Cleveland BioLabs, she worked as a Project Scientist in the Department of Molecular Genetics at The Cleveland Clinic.
Dr. Gurova earned her medical degree from the Sechenov Medical Academy and a doctoral degree in experimental oncology from the Blokhin Cancer Research Center, both located in Moscow, Russia.
Dr. Gurova’s research interests are focused on the discovery and development of new anticancer drugs. Specifically, she identified a new class of prospective anticancer agents ...
Tatiana Semiglazova, MD, DSci, Professor
Professor Semiglazova is an oncologist of the highest category. Her professional interests include the development of innovative and improvement of existing methods of drug therapy and medical rehabilitation of cancer patients.
Under her guidance, several state tasks on the development of modern diagnostic methods and the integrated treatment of malignant neoplasms in adults and children have been completed.
Over the past 5 years, Prof. Semiglazova has been a leading specialist in the field of medical rehabilitation of cancer patients, a new clinical area in the Russian Federation. Professor Semiglazova is the deputy editor-in-chief of the newly ...